New York Health Stock Performance
| BBAL Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and New York are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days New York Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, New York is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
Last Split Factor 1:1.5 | Last Split Date 2003-01-03 |
1 | Why This Health Care Stock Has Gained 35 percent This Week - Investopedia | 11/26/2025 |
2 | Hims and Hers to offer weight-loss treatments in UK - Reuters | 12/10/2025 |
3 | New York stock market closes higher in holiday-shortened session - Anadolu Ajans | 12/25/2025 |
4 | 5 things to know for Dec. 31 New Years Eve, Health care policy, SNAP restrictions, Stock market, MetroCard retired - CNN | 12/31/2025 |
5 | UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround - CNBC | 01/27/2026 |
New York Relative Risk vs. Return Landscape
If you would invest 0.01 in New York Health on November 15, 2025 and sell it today you would earn a total of 0.00 from holding New York Health or generate 0.0% return on investment over 90 days. New York Health is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than New, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
New York Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of New York for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for New York Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| New York Health generated a negative expected return over the last 90 days | |
| New York Health has some characteristics of a very speculative penny stock | |
| New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 44.4 M. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 7.35 M. | |
| New York Health currently holds about 5.37 M in cash with (88.61 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| New York Health has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround - CNBC |
New York Fundamentals Growth
New Stock prices reflect investors' perceptions of the future prospects and financial health of New York, and New York fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on New Stock performance.
| Return On Asset | 0.0364 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 335.37 K | ||||
| Price To Earning | 0.01 X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 44.4 M | ||||
| Gross Profit | 7.35 M | ||||
| EBITDA | 1.04 M | ||||
| Net Income | (1.05 M) | ||||
| Cash And Equivalents | 5.37 M | ||||
| Cash Per Share | 0.16 X | ||||
| Total Debt | 25.64 K | ||||
| Current Ratio | 0.77 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (88.61 K) | ||||
| Market Capitalization | 335.33 K | ||||
| Total Asset | 12.42 M | ||||
| Working Capital | (4.04 M) | ||||
| Current Asset | 13.38 M | ||||
| Current Liabilities | 17.42 M | ||||
About New York Performance
By examining New York's fundamental ratios, stakeholders can obtain critical insights into New York's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that New York is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.11) | (0.12) | |
| Return On Capital Employed | (0.39) | (0.37) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | 0.43 | 0.45 |
Things to note about New York Health performance evaluation
Checking the ongoing alerts about New York for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for New York Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| New York Health generated a negative expected return over the last 90 days | |
| New York Health has some characteristics of a very speculative penny stock | |
| New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 44.4 M. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 7.35 M. | |
| New York Health currently holds about 5.37 M in cash with (88.61 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| New York Health has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround - CNBC |
- Analyzing New York's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether New York's stock is overvalued or undervalued compared to its peers.
- Examining New York's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating New York's management team can have a significant impact on its success or failure. Reviewing the track record and experience of New York's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of New York's stock. These opinions can provide insight into New York's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in New York Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.